27976-27-8Relevant articles and documents
Synthetic method of 3-(6-phenylhexyl) phenylboronic acid and derivatives thereof
-
Paragraph 0021-0023; 0026-0030; 0033-0037; 0040-0044; ..., (2021/07/17)
The invention discloses a synthetic method of 3-(6-phenylhexyl) phenylboronic acid and derivatives thereof, and relates to the technical field of chemical synthesis. The synthesis method of 3-(6-phenylhexyl) phenylboronic acid and derivatives thereof comprises the following synthesis steps: S1, synthesizing an intermediate H from a reactant B and a reactant D by utilizing a low-temperature synthesis step; S2, synthesizing an intermediate I from the reactant F and the intermediate H by utilizing a low-temperature synthesis step; and S3, synthesizing a finished product from a reactant G and the intermediate I by utilizing a low-temperature synthesis step. The invention provides the novel synthesis method of 3-(6-phenylhexyl) phenylboronic acid and derivatives thereof, the reaction steps are shortened to three steps, the materials are simple, the raw materials can be recycled, the reaction yield is improved, and the method has a series of advantages of short reaction time, simplicity in operation, capability of amplifying continuous production, reduction of the reaction cost and the like.
Toward the discovery of dual HCMV-VZV inhibitors: Synthesis, structure activity relationship analysis, and cytotoxicity studies of long chained 2-uracil-3-yl-N-(4-phenoxyphenyl)acetamides
Babkov, Denis A.,Khandazhinskaya, Anastasia L.,Chizhov, Alexander O.,Andrei, Graciela,Snoeck, Robert,Seley-Radtke, Katherine L.,Novikov, Mikhail S.
, p. 7035 - 7044 (2015/11/11)
The need for novel therapeutic options to fight herpesvirus infections still persists. Herein we report the design, synthesis and antiviral evaluation of a new family of non-nucleoside antivirals, derived from 1-[ω-(4-bromophenoxy)alkyl]uracil derivatives - previously reported inhibitors of human cytomegalovirus (HCMV). Introduction of the N-(4-phenoxyphenyl)acetamide side chain at N3 increased their potency and widened activity spectrum. The most active compounds in the series exhibit submicromolar activity against different viral strains of HCMV and varicella zoster virus (VZV) replication in HEL cell cultures. Inactivity against other DNA and RNA viruses, including herpes simplex virus 1/2, points to a novel mechanism of antiviral action.
RECYCLING OF ORGANOTIN COMPOUNDS
-
Page/Page column 44, (2013/12/03)
A method for the synthesis of a first organic molecule, said method comprising the steps of: a) Reacting a first reactant with an organotin reactant having at least one optionally substituted organic group having from 5 to 20 carbon atoms selected from alkyl, alkenyl, alkynyl, alkoxyalkyl, alkoxy, alkylthioalkyl, carboxylates and alkylaminoalkyl groups, thereby forming a mixture of a product and a tin-containing by-product, and b) Removing most of the tin-containing by-product from said mixture in such a way as to provide a purified product comprising less than 1000 ppm of remaining tin-containing by- product, wherein said step of removing most of said tin-containing by-product is either an extraction between a first liquid and a second liquid, said second liquid being more polar than said first liquid and at least partly immiscible therewith or is a reversed phase chromatography.